Skip to main content
Top
Published in: Gastric Cancer 1/2017

01-01-2017 | Original Article

Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study

Authors: Massimiliano Bissolati, Matteo Desio, Fausto Rosa, Stefano Rausei, Daniele Marrelli, Gian Luca Baiocchi, Giovanni De Manzoni, Damiano Chiari, Giovanni Guarneri, Fabio Pacelli, Lorenzo De Franco, Sarah Molfino, Chiara Cipollari, Elena Orsenigo

Published in: Gastric Cancer | Issue 1/2017

Login to get access

Abstract

Background

Resection margin (RM) involvement is associated with negative prognosis after gastrectomy. Intraoperative frozen section (IFS) analysis allows radical resection to be achieved in a single operation but is time-consuming and resource-consuming. The aim of this study was to assess risk factors associated with RM involvement to identify patients who would benefit from IFS analysis.

Methods

We retrospectively analyzed patients who underwent gastrectomy with curative intent for gastric or esophagogastric junction (EGJ) cancer from 2000 to 2014 in six Italian hospitals. RM status was assessed by IFS analysis and/or definitive histopathology examination. A set of 21 potential risk factors were compared in a multivariate analysis between patients with positive RMs on IFS analysis or definitive histopathology examination and a control cohort of similar patients with negative RMs, with the samples stratified into three subgroups (T1, T2–T4 Lauren intestinal pattern, T2–T4 Lauren diffuse/mixed pattern).

Results

One hundred forty-five patients had positive RMs. Survival was significantly worse in positive RM patients than in negative RM patients (89.5 months vs 28.9 months). Multivariate analysis showed that in T1 cancers a margin distance of less than 2 cm is a risk factor for RM involvement (odds ratio 15.7), in T2–T4 intestinal pattern cancers, serosa invasion (odds ratio 6.0), EGJ location (odds ratio 4.1), and a margin distance of less than 3 cm (odds ratio 4.0) are independent risk factors, and in T2–T4 diffuse/mixed pattern cancers, lymphatic infiltration (odds ratio 4.2), tumor diameter greater than 4 cm (odds ratio 3.5), EGJ location (odds ratio 2.8), and serosa invasion (odds ratio 2.2) are independent risk factors.

Conclusions

Survival after gastrectomy is negatively affected by positive RMs. IFS analysis should be routinely used in patients with a high risk of positive RMs, especially in diffuse pattern cancers.
Literature
1.
go back to reference Morgagni P, Garcea D, Marrelli D, de Manzoni G, Natalini G, Kurihara H, Marchet A, Vittimberga G, Saragoni L, Roviello F, Di Leo A, De Santis F, Panizza V, Nitti D. Does resection line involvement affect prognosis in early gastric cancer patients? An Italian multicentric study. World J Surg. 2006;30(4):585–9.CrossRefPubMed Morgagni P, Garcea D, Marrelli D, de Manzoni G, Natalini G, Kurihara H, Marchet A, Vittimberga G, Saragoni L, Roviello F, Di Leo A, De Santis F, Panizza V, Nitti D. Does resection line involvement affect prognosis in early gastric cancer patients? An Italian multicentric study. World J Surg. 2006;30(4):585–9.CrossRefPubMed
2.
go back to reference Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute. J Surg Oncol. 2007;95(6):461–8.CrossRefPubMed Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute. J Surg Oncol. 2007;95(6):461–8.CrossRefPubMed
3.
go back to reference Sun Z, Li DM, Wang ZN, Huang BJ, Xu Y, Li K, Xu HM. Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection. Ann Surg Oncol. 2009;16(11):3028–37.CrossRefPubMed Sun Z, Li DM, Wang ZN, Huang BJ, Xu Y, Li K, Xu HM. Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection. Ann Surg Oncol. 2009;16(11):3028–37.CrossRefPubMed
4.
go back to reference Morgagni P, Garcea D, Marrelli D, De Manzoni G, Natalini G, Kurihara H, Marchet A, Saragoni L, Scarpi E, Pedrazzani C, Di Leo A, De Santis F, Panizzo V, Nitti D, Roviello F. Resection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patients. World J Surg. 2008;32(12):2661–7.CrossRefPubMed Morgagni P, Garcea D, Marrelli D, De Manzoni G, Natalini G, Kurihara H, Marchet A, Saragoni L, Scarpi E, Pedrazzani C, Di Leo A, De Santis F, Panizzo V, Nitti D, Roviello F. Resection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patients. World J Surg. 2008;32(12):2661–7.CrossRefPubMed
5.
go back to reference Nagata T, Ichikawa D, Komatsu S, Inoue K, Shiozaki A, Fujiwara H, Okamoto K, Sakakura C, Otsuji E. Prognostic impact of microscopic positive margin in gastric cancer patients. J Surg Oncol. 2011;104(6):592–7.CrossRefPubMed Nagata T, Ichikawa D, Komatsu S, Inoue K, Shiozaki A, Fujiwara H, Okamoto K, Sakakura C, Otsuji E. Prognostic impact of microscopic positive margin in gastric cancer patients. J Surg Oncol. 2011;104(6):592–7.CrossRefPubMed
6.
go back to reference Bozzetti F, Bonfanti G, Bufalino R, Menotti V, Persano S, Andreola S, Doci R, Gennari L. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg. 1982;196(6):685–90.CrossRefPubMedPubMedCentral Bozzetti F, Bonfanti G, Bufalino R, Menotti V, Persano S, Andreola S, Doci R, Gennari L. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg. 1982;196(6):685–90.CrossRefPubMedPubMedCentral
7.
go back to reference Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, Ashley SW, Zinner MJ, Whang EE. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199(6):880–6.CrossRefPubMed Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, Ashley SW, Zinner MJ, Whang EE. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199(6):880–6.CrossRefPubMed
8.
go back to reference Papachristou DN, Fortner JG. Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol. 1981;18(1):47–53.CrossRefPubMed Papachristou DN, Fortner JG. Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol. 1981;18(1):47–53.CrossRefPubMed
9.
go back to reference Kim JH, Park SS, Kim J, Boo YJ, Kim SJ, Mok YJ, Kim CS. Surgical outcomes for gastric cancer in the upper third of the stomach. World J Surg. 2006; 30(10):1870–6; discussion 1877–8. Kim JH, Park SS, Kim J, Boo YJ, Kim SJ, Mok YJ, Kim CS. Surgical outcomes for gastric cancer in the upper third of the stomach. World J Surg. 2006; 30(10):1870–6; discussion 1877–8.
10.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.CrossRef
11.
go back to reference Ferreiro JA, Myers JL, Bostwick DG. Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester. Mayo Clin Proc. 1995;70(12):1137–41.CrossRefPubMed Ferreiro JA, Myers JL, Bostwick DG. Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester. Mayo Clin Proc. 1995;70(12):1137–41.CrossRefPubMed
12.
go back to reference Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH. Intraoperative frozen section margin evaluation in gastric cancer of the cardia surgery. Hepatogastroenterology. 2006;53(72):976–8.PubMed Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH. Intraoperative frozen section margin evaluation in gastric cancer of the cardia surgery. Hepatogastroenterology. 2006;53(72):976–8.PubMed
13.
go back to reference DiNardo LJ, Lin J, Karageorge LS, Powers CN. Accuracy, utility, and cost of frozen section margins in head and neck cancer surgery. Laryngoscope. 2000;110(10 Pt 1):1773–6.CrossRefPubMed DiNardo LJ, Lin J, Karageorge LS, Powers CN. Accuracy, utility, and cost of frozen section margins in head and neck cancer surgery. Laryngoscope. 2000;110(10 Pt 1):1773–6.CrossRefPubMed
14.
go back to reference Wang SY, Yeh CN, Lee HL, Liu YY, Chao TC, Hwang TL, Jan YY, Chen MF. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol. 2009;16(10):2738–43.CrossRefPubMed Wang SY, Yeh CN, Lee HL, Liu YY, Chao TC, Hwang TL, Jan YY, Chen MF. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol. 2009;16(10):2738–43.CrossRefPubMed
15.
go back to reference Woo JW, Ryu KW, Park JY, Eom BW, Kim MJ, Yoon HM, Park SR, Kook MC, Choi IJ, Kim YW, Park YI. Prognostic impact of microscopic tumor involved resection margin in advanced gastric cancer patients after gastric resection. World J Surg. 2014;38(2):439–46.CrossRefPubMed Woo JW, Ryu KW, Park JY, Eom BW, Kim MJ, Yoon HM, Park SR, Kook MC, Choi IJ, Kim YW, Park YI. Prognostic impact of microscopic tumor involved resection margin in advanced gastric cancer patients after gastric resection. World J Surg. 2014;38(2):439–46.CrossRefPubMed
16.
go back to reference Peters SR. A practical guide to frozen section technique; New York: Springer Science+Business Media; 2010. Peters SR. A practical guide to frozen section technique; New York: Springer Science+Business Media; 2010.
17.
go back to reference Rowinsky EK. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Annu Rev Med. 2004;55:433–57.CrossRefPubMed Rowinsky EK. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Annu Rev Med. 2004;55:433–57.CrossRefPubMed
18.
go back to reference Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680–6.CrossRefPubMed Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680–6.CrossRefPubMed
19.
go back to reference Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, Yakeishi Y, Matsukuma A, Enjoji M. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer. 1992;70(5):1030–7.CrossRefPubMed Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, Yakeishi Y, Matsukuma A, Enjoji M. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer. 1992;70(5):1030–7.CrossRefPubMed
20.
go back to reference Bickenbach KA, Gonen M, Strong V, Brennan MF, Coit DG. Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol. 2013;20(8):2663–8.CrossRefPubMed Bickenbach KA, Gonen M, Strong V, Brennan MF, Coit DG. Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol. 2013;20(8):2663–8.CrossRefPubMed
21.
go back to reference Songun I, Bonenkamp JJ, Hermans J, van Krieken JH, van de Velde CJ. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer. 1996;32A(3):433–7.CrossRefPubMed Songun I, Bonenkamp JJ, Hermans J, van Krieken JH, van de Velde CJ. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer. 1996;32A(3):433–7.CrossRefPubMed
22.
go back to reference Cascinu S, Giordani P, Catalano V, Agostinelli R, Catalano G. Resection-line involvement in gastric cancer patients undergoing curative resections: implications for clinical management. Jpn J Clin Oncol. 1999;29(6):291–3.CrossRefPubMed Cascinu S, Giordani P, Catalano V, Agostinelli R, Catalano G. Resection-line involvement in gastric cancer patients undergoing curative resections: implications for clinical management. Jpn J Clin Oncol. 1999;29(6):291–3.CrossRefPubMed
23.
go back to reference Lee JH, Ahn SH, Parkdo J, Kim HH, Lee HJ, Yang HK. Clinical impact of tumor infiltration at the transected surgical margin during gastric cancer surgery. J Surg Oncol. 2012;106(6):772–6.CrossRefPubMed Lee JH, Ahn SH, Parkdo J, Kim HH, Lee HJ, Yang HK. Clinical impact of tumor infiltration at the transected surgical margin during gastric cancer surgery. J Surg Oncol. 2012;106(6):772–6.CrossRefPubMed
24.
go back to reference Kim SH, Karpeh MS, Klimstra DS, Leung D, Brennan MF. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg. 1999;3(1):24–33.CrossRefPubMed Kim SH, Karpeh MS, Klimstra DS, Leung D, Brennan MF. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg. 1999;3(1):24–33.CrossRefPubMed
25.
go back to reference Jang YJ, Park MS, Kim JH, Park SS, Park SH, Kim SJ, Kim CS, Mok YJ. Advanced gastric cancer in the middle one-third of the stomach: should surgeons perform total gastrectomy? J Surg Oncol. 2010;101(6):451–6.PubMed Jang YJ, Park MS, Kim JH, Park SS, Park SH, Kim SJ, Kim CS, Mok YJ. Advanced gastric cancer in the middle one-third of the stomach: should surgeons perform total gastrectomy? J Surg Oncol. 2010;101(6):451–6.PubMed
26.
go back to reference Lee JH, Kim YI. Which is the optimal extent of resection in middle third gastric cancer between total gastrectomy and subtotal gastrectomy? J Gastric Cancer. 2010;10(4):226–33.CrossRefPubMedPubMedCentral Lee JH, Kim YI. Which is the optimal extent of resection in middle third gastric cancer between total gastrectomy and subtotal gastrectomy? J Gastric Cancer. 2010;10(4):226–33.CrossRefPubMedPubMedCentral
27.
go back to reference Torp SH, Skjørten FJ. The reliability of frozen section diagnosis. Acta Chir Scand. 1990;156(2):127–30.PubMed Torp SH, Skjørten FJ. The reliability of frozen section diagnosis. Acta Chir Scand. 1990;156(2):127–30.PubMed
28.
go back to reference Raziee HR, Cardoso R, Seevaratnam R, Mahar A, Helyer L, Law C, Coburn N. Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival. Gastric Cancer. 2012;15(Suppl 1):S116–24.CrossRefPubMed Raziee HR, Cardoso R, Seevaratnam R, Mahar A, Helyer L, Law C, Coburn N. Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival. Gastric Cancer. 2012;15(Suppl 1):S116–24.CrossRefPubMed
29.
go back to reference Kim SY, Hwang YS, Sohn TS, Oh SJ, Choi MG, Noh JH, Bae JM, Kim S. The predictors and clinical impact of positive resection margins on frozen section in gastric cancer surgery. J Gastric Cancer. 2012;12(2):113–9.CrossRefPubMedPubMedCentral Kim SY, Hwang YS, Sohn TS, Oh SJ, Choi MG, Noh JH, Bae JM, Kim S. The predictors and clinical impact of positive resection margins on frozen section in gastric cancer surgery. J Gastric Cancer. 2012;12(2):113–9.CrossRefPubMedPubMedCentral
Metadata
Title
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study
Authors
Massimiliano Bissolati
Matteo Desio
Fausto Rosa
Stefano Rausei
Daniele Marrelli
Gian Luca Baiocchi
Giovanni De Manzoni
Damiano Chiari
Giovanni Guarneri
Fabio Pacelli
Lorenzo De Franco
Sarah Molfino
Chiara Cipollari
Elena Orsenigo
Publication date
01-01-2017
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2017
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-015-0589-6

Other articles of this Issue 1/2017

Gastric Cancer 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.